
Mission to New York: Phase II clinical trials progress and Heliance successfully tested
A new mission organized by Hemerion in the United States enabled us to test the new version of the Heliance laser diffuser and to specify the outlines of the phase 2 trial in the treatment of glioblastoma. After a first mission in April 2022 in Boston, the Hemerion team continues its clinical development in the …